Abstract: Methods, apparatus, and processor-readable storage media for automatically remediating storage device issues using machine learning techniques are provided herein. An example computer-implemented method includes obtaining performance-related information pertaining to one or more storage devices; automatically determining one or more workflows to be executed in connection with remediating at least one issue attributed to at least a portion of the one or more storage devices, wherein determining the one or more workflows comprises applying one or more machine learning techniques to the obtained performance-related information; and performing one or more automated actions based at least in part on the one or more workflows.

Abstract: Methods, apparatus, and processor-readable storage media for automatically remediating storage device issues using machine learning techniques are provided herein. An example computer-implemented method includes obtaining performance-related information pertaining to one or more storage devices; automatically determining one or more workflows to be executed in connection with remediating at least one issue attributed to at least a portion of the one or more storage devices, wherein determining the one or more workflows comprises applying one or more machine learning techniques to the obtained performance-related information; and performing one or more automated actions based at least in part on the one or more workflows.

Abstract: Disclosed herein are modified saponins or fractions thereof obtainable by modification of a crude Quillaja saponaria extract or by modification of purified saponins obtainable from a crude Quillaja saponaria extract useful in pharmaceutical compositions for enhancing the transport of pharmacologically active substances across mucous membranes of an animal. Also disclosed are modified saponins having reduced irritability wherein the aldehyde group is reduced and the fatty acid moiety may be removed by hydrolysis. Also disclosed are pharmaceutical compositions comprising the modified saponins of the invention.

Abstract: Saponin/antigen conjugates and the use thereof for enhancing immune responses in individuals are disclosed. The saponins may be substantially pure or mixtures of saponins.

Abstract: Disclosed herein are modified saponins or fractions thereof obtainable by modification of a crude Quillaja saponaria extract or by modification of purified saponins obtainable from a crude Quillaja saponaria extract useful in pharmaceutical compositions for enhancing the transport of pharmacologically active substances across mucous membranes of an animal. Also disclosed are modified saponins having reduced irritability wherein the aldehyde group is reduced and the fatty acid moiety may be removed by hydrolysis. Also disclosed are pharmaceutical compositions comprising the modified saponins of the invention.

Abstract: Methods for enhancing the transport of pharmacologically active substances across mucous membranes of an animal by administration of pharmaceutical compositions comprising modified saponins or fractions thereof obtainable by modification of a crude Quillaja saponaria extract or by modification of purified saponins obtainable from a crude Quillaja saponaria extract. Also disclosed are modified saponins having reduced irritability wherein the fatty acid moiety is removed by hydrolysis or the aldehyde group is reduced. Also disclosed are pharmaceutical compositions comprising the modified saponins of the invention.